Sonic Hedgehog Protein Expression in Various Thyroid Tissues and Its Clinical Implication.
10.16956/kjes.2011.11.4.234
- Author:
Kuhn Soo RYU
1
;
Ok Jun LEE
;
Wun Jae KIM
;
Sung Su PARK
;
Dong Ju KIM
;
Jin Woo PARK
;
Jae Woon CHOI
;
Lee Chan JANG
;
Orlo H CLARK
Author Information
1. Department of Surgery, Chungbuk National University College of Medicine, Cheongju, Korea. webjwpark@chungbuk.ac.kr
- Publication Type:Original Article
- Keywords:
Sonic hedghog;
Cyclopamine;
Thyroid cancer;
Redifferentiation
- MeSH:
Cell Differentiation;
Cell Line;
Embryonic Development;
Female;
Hedgehog Proteins*;
Hedgehogs;
Pregnancy;
RNA, Messenger;
Thyroglobulin;
Thyroid Gland*;
Thyroid Neoplasms
- From:Korean Journal of Endocrine Surgery
2011;11(4):234-241
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The Hedgehog (Hh) signaling pathway is important in embryonic development including cell differentiation and proliferation. Recently, activation of this pathway has been implicated in several forms of solid cancers. We investigated sonic hedgehog (Shh) protein expression and its relation to differentiation and clinicopathologic characteristics in thyroid cancer cell lines and tissues. METHODS: FTC-236, FTC-238, and XTC-1. We made tissue microarray slides using 80 thyroid surgical specimen: 40 benign and 40 malignant lesions. Immunohistochemical staining was performed using anti-Shh antibody. mRNA expression of NIS, thyroglobulin, and CD97 were evaluated by RT-PCR. Cyclopamine was used as a Shh signal inhibitor. RESULTS: Shh expression was more prominent in TPC-1, FTC-133, and XTC-1 cell lines than the others. Cyclopamine downregulated CD97 and upregulated thyroglobulin mRNA expression, but did not induce mRNA expression of NIS. Thyroid tissues showed varied expression of Shh in both benign and malignant diseases. Shh expression was detected in 38 of 50 (76%) normal, in 18 of 25 (72%) non-neoplastic benign, in nine of 15 (60%) benign tumors, and in 31 of 40 (77%) malignant tumors. Shh over-expression was significantly less frequent in papillary thyroid carcinomas than in normal or benign thyroid tissues. In addition, Shh protein expression did not relate to clinicopathologic characteristics in papillary thyroid carcinomas. CONCLUSION: Thyroid tissues and cell lines vary in expression of Shh. Cyclopamine can induce redifferentiation in thyroid cancer cell lines. Shh protein expression, however, is unrelated to clinicopathologic characteristics in papillary thyroid carcinomas.
